Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Antonio Pérez-Martínez, MD, PhD, Hospital Universitario La Paz, Madrid, Spain, discusses his talk from the 2020 EBMT meeting outlining NKG2D CAR T-cells and how they are not affected by soluble NKG2D ligands. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.